MedPath

成都赛璟生物医药科技有限公司

Ownership
-
Established
2020-07-09
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

2

NMPA:2

Drug Approvals

Ursodeoxycholic Acid Oral Suspension

Product Name
熊去氧胆酸口服混悬液
Approval Number
国药准字H20253746
Approval Date
Apr 1, 2025
NMPA

Ursodeoxycholic Acid Capsules

Product Name
熊去氧胆酸胶囊
Approval Number
国药准字H20223618
Approval Date
Aug 23, 2022
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.